VivoSeq
Other

Nasal Congestion

32

Pipeline Programs↗

1

Active Trials↗

14

Companies Involved↗

Nasal congestion is a moderately active landscape with 32 programs across 14 companies. The most active players are Hyundai Pharmaceutical Co., LTD., Exela Pharma Sciences, LLC., GSK. 18 therapies are approved with 8 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

53/100

Pipeline Velocity

6/100

Mech. Concentration

46/100

Completion Rate

86/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

H

Hyundai Pharmaceutical Co., LTD.

1 program

Phase 1E

Exela Pharma Sciences, LLC.

1 program

Phase 3GSK logo

GSK

3 programs

Phase 3K

Kenvue Brands

3 programs

ApprovedP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

2 programs

ApprovedA

Azurity Pharmaceuticals

1 program

Approved

Pipeline

Programs by Phase

Analysis

Trial Status

8

clinical trials

Completed6 · 75%
Not yet recruiting1 · 13%
Terminated1 · 13%

Clinical Trials

Trial Activity

8 trials

Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion
Not yet recruiting·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·N/A·NCT07114107·200 enrolled
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
Completed·EEMS·Phase 3·NCT01533220·132 enrolled
Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
Completed·Bayer logoBayer·Phase 3·NCT01413958·575 enrolled
A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.
Completed·MMcNeil AB·Phase 3·NCT03439436·140 enrolled
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
Completed·JJohnson & Johnson Consumer and Personal Products Worldwide·Phase 4·NCT00648973·1,021 enrolled
Efficacy and Safety of Pediatric Drugs in Nasal Congestion
Completed·EEMS·Phase 3·NCT02601235·292 enrolled
A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold
Completed·PPerrigo Company·Phase 3·NCT01744106·565 enrolled
Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion
Terminated·SSt. Olavs Hospital·N/A·NCT01562093·14 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)